News headlines about Align Technology (NASDAQ:ALGN) have trended somewhat positive on Wednesday, according to Accern Sentiment Analysis. The research group ranks the sentiment of news coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Align Technology earned a news sentiment score of 0.14 on Accern’s scale. Accern also assigned headlines about the medical equipment provider an impact score of 46.6627586675813 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Here are some of the news stories that may have effected Accern’s analysis:

A number of analysts have commented on the stock. Goldman Sachs Group, Inc. (The) increased their price target on shares of Align Technology from $185.00 to $210.00 and gave the company a “buy” rating in a research note on Friday, September 15th. Robert W. Baird restated a “buy” rating on shares of Align Technology in a research note on Tuesday, September 12th. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $200.00 target price on shares of Align Technology in a report on Monday, September 11th. Zacks Investment Research cut shares of Align Technology from a “strong-buy” rating to a “hold” rating in a report on Monday, August 21st. Finally, Stifel Nicolaus reiterated a “buy” rating and issued a $205.00 target price (up from $200.00) on shares of Align Technology in a research note on Monday, August 7th. One equities research analyst has rated the stock with a hold rating and ten have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of $179.82.

Shares of Align Technology (NASDAQ ALGN) opened at 186.45 on Wednesday. The company has a market capitalization of $14.94 billion, a P/E ratio of 63.85 and a beta of 1.54. The company has a 50-day moving average price of $180.24 and a 200 day moving average price of $150.99. Align Technology has a 1-year low of $83.27 and a 1-year high of $190.04.

Align Technology (NASDAQ:ALGN) last announced its quarterly earnings data on Thursday, July 27th. The medical equipment provider reported $0.85 earnings per share for the quarter, beating the consensus estimate of $0.73 by $0.12. The business had revenue of $356.50 million during the quarter, compared to analyst estimates of $343.43 million. Align Technology had a return on equity of 23.87% and a net margin of 19.18%. Align Technology’s revenue was up 32.3% compared to the same quarter last year. During the same period in the prior year, the company earned $0.62 earnings per share. Equities research analysts anticipate that Align Technology will post $3.40 EPS for the current year.

ILLEGAL ACTIVITY WARNING: “Somewhat Positive Press Coverage Somewhat Unlikely to Affect Align Technology (ALGN) Share Price” was first posted by Watch List News and is owned by of Watch List News. If you are reading this news story on another domain, it was stolen and reposted in violation of US & international trademark & copyright law. The original version of this news story can be accessed at https://www.watchlistnews.com/somewhat-positive-press-coverage-somewhat-unlikely-to-affect-align-technology-algn-share-price/1606364.html.

Align Technology Company Profile

Align Technology, Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment.

Insider Buying and Selling by Quarter for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.